Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care

Trial Identifier: D6930L00001
Sponsor: AstraZeneca
Collaborator:
Premier HealthCare Solutions Inc.
Start Date: May 2024
Primary Completion Date: April 2026
Study Completion Date: April 2026
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, CA North Hollywood, CA, US, 91602
US, CA Walnut Creek, CA, US, 94598
US, KY Louisville, KY, US, 40217
US, MA Boston, MA, US, 02111
US, MI Ann Arbor, MI, US, 48109
US, MI Flint, MI, US, 48532
US, MN Minneapolis, MN, US, 55425
US, NC Asheville, NC, US, 28803
US, NC Greenville, NC, US, 27834
US, PA Du Bois, PA, US, 15801
US, TX Austin, TX, US, 78738